Rise Nano Optics Ltd. News Releases

Rise Nano Optics Announces FDA Class I Device Classification for SPECTRAGUARD(TM) Nano-Optic Lens Technology

Mon, 23 Mar 2026 07:00:00 -0400

Proprietary, patented technology providing vision protection beyond UV and Blue Light Vancouver, British Columbia--(Newsfile Corp. - March 23, 2026) - Rise Nano Optics Ltd. (CSE: EYE) ("Rise" or the "Company") a health technology company advancing vision care through patented nanotechnology lens solutions, today announced that its proprietary, patented SPECTRAGUARD™ nano-optic lens technology is FDA registered and has been classified by the U.S. Food and Drug Administration (FDA) as a Class I...

Rise Nano Optics Appoints Erik Ritchie as Chief Commercial Officer to Lead North American Commercialization Strategy

Tue, 17 Mar 2026 07:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - March 17, 2026) - Rise Nano Optics Ltd. (CSE: EYE) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced the appointment of Erik Ritchie as Chief Commercial Officer (CCO). Mr. Ritchie will lead Rise's North American commercialization strategy, overseeing go-to-market execution, operations, partnerships, and sales and marketing.Mr. Ritchie brings deep executive...

Rise Nano Optics to Commence Trading on the Canadian Securities Exchange Under the Symbol "EYE", Today, March 12, 2026

Thu, 12 Mar 2026 07:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - March 12, 2026) - Rise Nano Optics Ltd. (CSE: EYE) ("Rise" or the "Company") is pleased to announce that it has received approval to list its common shares (the "Common Shares") on the Canadian Securities Exchange (the "CSE"). Trading is expected to commence on the CSE under the symbol "EYE" at the open of markets on March 12, 2026. Inas Said, CEO of Rise commented, "Listing publicly represents an important milestone for Rise Nano Optics and...

Rise Health Nano Optics Granted Third U.S. Patent for Breakthrough Nano-Optic Technology Advancing Preventative Vision Care

Tue, 04 Nov 2025 07:00:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - November 4, 2025) - Rise Health Nano Optics Inc. ("Rise" or the "Company"), a health technology innovator specializing in nano-optic solutions that effectively block wavelengths of light linked to vision stress and degenerative eye disease, is pleased to announce the granting of its third U.S. technology patent – U.S. Patent No. 12,383,955 (B2) – further strengthening its proprietary leadership position in advanced eye-protection nanomaterials....

Rise Health Nano Optics Achieves FDA Clearance Milestone Following Successful Biocompatibility Testing for EYEGUARD Lenses

Wed, 17 Sep 2025 04:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - September 17, 2025) - Rise Health Nano Optics Inc. ("Rise" or the "Company"), a health-tech innovator specializing in advanced, preventative optical solutions, is pleased to announce a major milestone in its regulatory pathway toward global market entry.Following a formal review meeting with the U.S. Food and Drug Administration ("FDA") on April 3, 2025, the FDA confirmed:Classification Agreement: EYEGUARD™ lenses are confirmed as Class I, exempt...